Top 10 Pharmacies in Saudi Arabia · 2026

    Top 10 Pharmacies in Saudi Arabia (2026): Ranked List of Pharmacy Chains

    The top 10 pharmacies in Saudi Arabia, ranked by the number of stores each operator has publicly disclosed, are Nahdi Medical Company (1,217 pharmacies), Al-Dawaa Medical Services (975), United Pharmacies (about 500, plus the Kunooz chain acquired in 2026), Innova Pharmacies (200+), Zahrat Al Rawdah / Planet Pharmacies under BinDawood Holding (173), Al Mujtama (125), Adam Pharmacy (70), Whites Pharmacy (about 50), Boots operated by Alshaya (about 28) and the hospital-affiliated Dr. Sulaiman Al Habib pharmacies. Together the two listed leaders alone account for roughly one in five of the Kingdom’s ~10,000 retail pharmacies.

    The Saudi retail pharmacy channel is unusually consolidated at the top and highly fragmented below it. Nahdi and Al-Dawaa are both listed on the Saudi Exchange (Tadawul) and run nationwide networks with centralised buying, private label and loyalty programmes; a second tier of regional chains is consolidating quickly through acquisitions; and hospital-affiliated outpatient pharmacies, hypermarket in-store pharmacies, independents and a fast-growing digital layer make up the rest.

    Every figure in the ranking below is taken from a public disclosure — annual reports, Saudi Exchange announcements, company websites or broker initiation notes — and each row cites its source. What public filings cannot tell you is category share, shelf presence or pharmacist recommendation for your product: BioNixus measures those through commissioned retail audits, mystery shopping, pharmacist recommendation studies and shopper research in Saudi Arabia.

    Updated 3 September 2026

    Request a proposalSee what we research

    Saudi Arabia

    Market

    Retail Pharmacy Chains

    Segment

    6

    research topics

    48h

    to a scoped proposal

    Quick answer

    What are the top 10 pharmacies in Saudi Arabia?

    Ranked by disclosed store count, the top 10 pharmacies in Saudi Arabia in 2026 are: 1) Nahdi Medical Company — 1,217 pharmacies; 2) Al-Dawaa Medical Services — 975; 3) United Pharmacies Group — about 500, targeting 600 after acquiring Kunooz; 4) Innova Pharmacies — 200+; 5) Zahrat Al Rawdah (Planet Pharmacies, now BinDawood Holding) — 173; 6) Al Mujtama Pharmacies — 125; 7) Adam Pharmacy (UniPharma) — 70; 8) Whites Pharmacy (GHC Group) — about 50; 9) Boots (Alshaya franchise) — about 28; 10) Dr. Sulaiman Al Habib hospital pharmacies. Nahdi and Al-Dawaa are Tadawul-listed and together hold roughly a fifth of all Saudi pharmacies.

    • Two listed national leadersNahdi (Tadawul: 4164) and Al-Dawaa (Tadawul: 4163) operate more than 2,100 pharmacies between them, serve 140+ cities each and lead in private label, loyalty and digital ordering.
    • A consolidating second tierUnited Pharmacies bought Kunooz in February 2026 and plans 100 openings this year; BinDawood Holding bought the 173-store Zahrat Al Rawdah (Planet) network from Julphar in 2025.
    • Non-traditional formats matterHospital-affiliated outpatient pharmacies (HMG, Al-Dawaa’s 31 outpatient sites), hypermarket in-store pharmacies (BinDawood, Danube, Panda, Lulu) and e-pharmacy apps capture demand pure retail analysis misses.
    • Share still needs primary measurementStore counts are public; category share, facings and pharmacist recommendation are not. Those come from a commissioned BioNixus retail audit with an agreed sample frame.

    BioNixus provides commissioned pharmacy channel research in Saudi Arabia — retail audits, mystery shopping, pharmacist recommendation studies, shopper research and trade margin work — for pharmaceutical and consumer health companies that need measured channel evidence behind the ranking.

    Named accounts

    Top 10 pharmacies in Saudi Arabia, ranked by disclosed store count (2026)

    Ranking uses the most recent public store count for each operator. Where an operator discloses a mix of formats (community pharmacies, dark stores, outpatient pharmacies) the note explains what the number includes. Counts move every quarter; the source link shows the disclosure date.
    #PharmacyStores (latest disclosure)Ownership and listingFootprint and positioningSource
    01Nahdi Medical Company1,217 pharmacies (H1 2026, Saudi Arabia and UAE); 1,173 in Saudi Arabia at 1H 2025Public — Saudi Exchange (Tadawul: 4164); headquartered in Jeddah138+ cities, ~97% population coverage, ~11.5% of all Saudi pharmacies; 14 polyclinics; online sales ~26% of retail revenueNahdi Investor Relations; ANB Capital initiation (2025)
    02Al-Dawaa Medical Services (DMSCO)975 pharmacies at end-2025 (952 community pharmacies + 23 dark stores) plus 31 outpatient pharmaciesPublic — Saudi Exchange (Tadawul: 4163); headquartered in Al Khobar145+ cities; strongest in the Eastern (≈39%) and Central (≈27%) regions; leading Wasfaty dispenser; one pharmacy in BahrainAl-Dawaa Annual Report 2025
    03United Pharmacies Group≈500 branches; plans 100 openings in 2026 to reach ≈600, excluding the acquired Kunooz network (40+ Riyadh stores)Private; headquartered in Makkah; acquired 100% of Kunooz Pharmacies for >SAR 100M (Feb 2026)44+ cities; targeting 13% market share by end-2026; Kunooz stores being rebranded as UnitedEnterpriseAM (Feb 2026)
    04Innova Pharmacies200+ branches across 12 citiesPrivate; founded 1994; headquartered in RiyadhRiyadh, Qassim, Hail and Makkah regions; family-pharmacy positioning with online store and deliveryInnova company profile
    05Zahrat Al Rawdah Pharmacies (Planet Pharmacies)173 retail pharmacies at acquisition (Feb 2025)Owned by BinDawood Holding (Tadawul: 4161) since 2025; bought from Julphar for SAR 441.1MBeing integrated with Danube and BinDawood grocery stores as the first Saudi grocer-owned pharmacy networkJulphar divestment announcement (Oct 2024)
    06Al Mujtama Pharmacies125 pharmacies (2023 disclosure)Private; founded 20019 cities; community-pharmacy format concentrated in central and western Saudi ArabiaKen Research, KSA retail pharmacy market
    07Adam Pharmacy70 branches; target of 100+ by end-2026Owned by UniPharma (pharmaceutical wholesaler); founded 2017; headquartered in RiyadhRiyadh, Jeddah, Makkah, Al Khobar, Tabuk and Medina; premium and e-commerce focus with 10,000+ SKUs onlineUniPharma retail page
    08Whites Pharmacy≈50 prime-location storesGHC Group (formerly also owner of Kunooz)Super-premium health, beauty and dermocosmetics positioning in Riyadh, Jeddah and Eastern Province mallsBolst Global, Saudi pharmacy chains
    09Boots (M.H. Alshaya franchise)≈28 Saudi stores listed on the Boots KSA store finder (of 111 Boots stores across Alshaya markets)Franchise operated by M.H. Alshaya Co. (Kuwait)Mall and high-street health-and-beauty format in Riyadh, Jeddah, Khobar, Dammam, Abha and secondary citiesBoots Saudi Arabia store locator
    10Dr. Sulaiman Al Habib (HMG) pharmaciesHospital-affiliated outpatient pharmacy network across HMG hospitals and medical towers (14 pharmacies per Saudi Exchange listing profile)Public — Saudi Exchange (Tadawul: 4013); headquartered in RiyadhCaptures prescriptions at the point of consultation in Riyadh, Al Khobar, Al Kharj, Jeddah and Dubai rather than in retail catchmentsSaudi Exchange company profile

    Store counts are as disclosed by each operator or its broker/regulator at the dates shown in the linked sources and are not audited by BioNixus. Nahdi’s 2024 annual report states its 1,156 Saudi pharmacies represent ~11.5% of the Kingdom’s total, implying roughly 10,000 retail pharmacies nationwide. Regional chains such as Tadawi, Seha and Dawaee, and hypermarket pharmacies inside Panda and Lulu, are excluded because no current public store count exists.

    Coverage

    What we research in the Saudi Arabia retail pharmacy chains market

    Retail audit and distribution measurement

    Measured in-store presence, facings, stock availability, out-of-stock incidence, and planogram compliance across chain, independent, and in-store pharmacy formats.

    Pharmacist recommendation research

    What pharmacists recommend by category and why, the influence of trade terms and detailing, and how substitution advice is given at the counter for OTC and switch products.

    Mystery shopping programmes

    Standardised covert visits testing product availability, staff advice quality, competitor conquesting, promotional execution, and compliance with agreed merchandising terms.

    Shopper and consumer research

    Why shoppers choose one pharmacy over another, basket composition, loyalty programme influence, price perception, and the growing role of app-based ordering and delivery.

    Trade margin and listing research

    Listing requirements, category management practice, promotional mechanics, and the commercial terms suppliers need to secure and sustain distribution with national chains.

    Insurance and Wasfaty dispensing dynamics

    How insurance-covered dispensing and the Wasfaty prescription service reshape footfall, prescription volume, and the balance between retail, hospital, and digital channels.

    Breakdown

    The Saudi retail pharmacy landscape: who operates in the channel

    Nahdi Medical Company

    The largest retail pharmacy operator in Saudi Arabia with 1,217 pharmacies (H1 2026), a nationwide network, a leading app and delivery offer, 14 polyclinics, and a Tadawul listing (4164).

    Al-Dawaa Medical Services

    The second-largest chain with 975 pharmacies at end-2025 plus 31 outpatient pharmacies, strongest in the Eastern and Central regions, the leading Wasfaty dispenser, and Tadawul-listed (4163).

    United Pharmacies and Innova

    The consolidating second tier: United (≈500 stores, Kunooz acquired 2026, 600 targeted) and Innova (200+ stores in 12 cities) compete on neighbourhood coverage and conventional dispensing plus OTC.

    Whites, Adam and Boots

    Premium health-and-beauty formats — Whites (GHC Group, ≈50 stores), Adam Pharmacy (UniPharma, 70 stores) and Boots (Alshaya franchise, ≈28 stores) — competing on store experience and dermocosmetics.

    Grocer-owned and regional chains, independents

    BinDawood Holding’s 173-store Zahrat Al Rawdah (Planet) network, Al Mujtama (125), Tadawi, Seha and a long tail of independents competing on locality, clinic proximity and personal relationships.

    Hospital-affiliated outpatient pharmacies

    Dispensing units attached to private hospital groups such as Dr. Sulaiman Al Habib, Mouwasat, and Almana, capturing prescriptions at the point of consultation rather than in retail catchments.

    Hypermarket and in-store pharmacies

    Pharmacy counters inside grocery and hypermarket formats including Panda, Danube, Lulu, and Carrefour, converting general retail footfall into consumer-health and OTC purchases.

    Digital and e-pharmacy platforms

    Chain-owned apps, quick-commerce delivery partnerships, and telehealth-linked dispensing services that are reshaping convenience expectations and repeat-purchase behaviour.

    What is moving

    What is shaping the Saudi retail pharmacy channel

    Chain consolidation

    National chains continue to professionalise category management, private label, and loyalty programmes, raising the commercial sophistication required from supplier trade teams.

    Digital and delivery adoption

    App-based ordering, rapid delivery, and telehealth-linked dispensing have shifted convenience expectations and created new competition for traditional walk-in footfall.

    Wasfaty and prescription routing

    The Wasfaty prescription service changes where publicly funded prescriptions are dispensed, affecting pharmacy footfall patterns and the retail-versus-institutional channel balance.

    Insurance coverage expansion

    Growth in insured lives increases covered dispensing, which shifts product mix and makes payer and formulary alignment relevant even in the retail environment.

    Consumer health and wellness growth

    Vitamins, supplements, dermocosmetics, and self-care categories drive basket value and margin, pushing chains towards beauty-and-wellness-led store formats.

    Pharmacist workforce localisation

    Saudisation of pharmacy roles is changing staffing profiles, language of counter advice, and training needs, all of which affect how recommendation influence operates.

    Market structure

    How the Saudi retail pharmacy market is structured

    The channel has a clear shape even without published share figures. A small group of national chains operates across the major population centres with centralised buying, category management, and loyalty infrastructure, which means listing decisions are made at head-office level rather than store by store. Below them, regional chains and independent community pharmacies compete on proximity, clinic relationships, and personal service. Suppliers therefore need two distinct route-to-market strategies: national negotiation for the chains, and distributor-led coverage for the fragmented tail.

    Non-traditional formats have become commercially significant. Hospital-affiliated outpatient pharmacies capture prescriptions at the point of consultation, hypermarket in-store pharmacies convert general retail traffic into consumer-health purchases, and digital platforms compete on convenience and repeat ordering. Each format has different assortment logic, margin expectations, and promotional mechanics. Treating the channel as a single retail block leads suppliers to over-invest in one format and lose share in another without ever seeing why.

    Dispensing economics are also shifting. Wasfaty routing of publicly funded prescriptions, expanding insurance coverage, and the growing weight of consumer health categories all change what a pharmacy earns per visit and therefore what it prioritises on shelf. BioNixus researches this environment directly through retail audits, pharmacist interviews, mystery shopping, and shopper studies, producing measured evidence for a specific category rather than a general industry commentary.

    Signals

    Where Saudi pharmacy retail demand concentrates

    Riyadh

    The largest retail catchment in the Kingdom, with the densest chain presence, strongest competition for prime locations, and the fastest adoption of delivery and app-based ordering.

    Jeddah and the Western Region

    A major urban market with high pharmacy density, seasonal demand shifts around pilgrimage traffic, and strong consumer health and dermocosmetics performance.

    Eastern Province

    Dammam, Khobar, and Dhahran combine high insured coverage through employer plans with established chain and hospital-affiliated pharmacy networks.

    Secondary cities and regional towns

    Markets where independent and regional pharmacies retain stronger relative share, distributor coverage is decisive, and price sensitivity is more pronounced.

    Fieldwork

    Who we interview

    Community and chain pharmacists

    Counter-level professionals whose recommendation, substitution advice, and category knowledge directly influence OTC and consumer health purchase decisions.

    Chain category and buying managers

    Head-office decision makers who control listing, planogram space, promotional calendars, private label strategy, and supplier trade terms.

    Distributors and trade partners

    Wholesale and distribution partners whose coverage, service levels, and independent-pharmacy relationships determine reach beyond the national chains.

    Shoppers and patients

    Consumers whose store choice, basket behaviour, price perception, and loyalty programme engagement determine where category demand is actually captured.

    Pharmaceutical and consumer health commercial teams

    Trade marketing, sales, and category leaders who need measured channel evidence to negotiate listings and allocate promotional investment credibly.

    Method

    How we size and validate the retail pharmacy chains opportunity

    • →Retail audits across chain, independent, hospital-affiliated, and in-store pharmacy formats measuring availability, facings, pricing, and promotional execution.
    • →Mystery shopping programmes using standardised scenarios to test pharmacist advice, competitor conquesting, and compliance with agreed merchandising terms.
    • →Pharmacist interviews and surveys covering recommendation drivers, category knowledge, substitution behaviour, and the influence of trade terms and detailing.
    • →Shopper research at and after the point of purchase covering store choice, basket composition, price perception, and digital versus in-store ordering behaviour.
    • →Trade and category management interviews with chain buyers and distributors on listing criteria, margin expectations, and promotional mechanics.

    Why BioNixus

    Why teams choose BioNixus for Saudi Arabia retail pharmacy chains research

    BioNixus brings global reach with local rigour — operating across the Americas, EMEA, and APAC with the country-level depth that generic research cannot replicate. Founded in regulated healthcare, we apply the same methodological standards to life sciences (pharma, biotech, medtech) and to adjacent sectors including B2B, FMCG, and industrial markets. We translate KOL, payer, and hospital evidence — and where relevant, buyer, channel, and consumer insight — into launch, access, and growth strategies built for board-level scrutiny.

    • ✓We cite public store counts and measure everything else — category share, facings and recommendation — rather than publishing unverifiable estimates.
    • ✓We audit chain, independent, hospital-affiliated, hypermarket, and digital formats separately, because they behave as different businesses.
    • ✓We recruit pharmacists directly, which is where OTC and consumer health recommendation influence is created.
    • ✓We run mystery shopping to standards that make results comparable across waves, cities, and competitor sets.
    • ✓We understand how Wasfaty routing and insurance dispensing reshape footfall and prescription flow.
    • ✓We deliver client-owned, category-specific channel evidence rather than a generic retail overview.

    Questions

    Frequently asked questions

    What are the top 10 pharmacies in Saudi Arabia in 2026?

    Ranked by disclosed store count: Nahdi Medical Company (1,217 pharmacies), Al-Dawaa Medical Services (975), United Pharmacies Group (about 500, plus the acquired Kunooz chain), Innova Pharmacies (200+), Zahrat Al Rawdah / Planet Pharmacies under BinDawood Holding (173), Al Mujtama Pharmacies (125), Adam Pharmacy (70), Whites Pharmacy (about 50), Boots operated by Alshaya (about 28) and the hospital-affiliated Dr. Sulaiman Al Habib pharmacies. Nahdi and Al-Dawaa are both listed on the Saudi Exchange and together operate more than 2,100 of the Kingdom’s roughly 10,000 retail pharmacies.

    Which is the largest pharmacy chain in Saudi Arabia?

    Nahdi Medical Company is the largest pharmacy chain in Saudi Arabia, with 1,217 pharmacies reported in the first half of 2026 across Saudi Arabia and the UAE (1,173 in the Kingdom at mid-2025), coverage of 138+ cities and roughly 97% of the population, and about 11.5% of all Saudi pharmacies by its own count. Al-Dawaa Medical Services is second with 975 pharmacies at the end of 2025 and is the leading dispenser on the Wasfaty prescription platform. Both are listed on Tadawul, so their store counts, revenue and expansion plans are disclosed quarterly.

    How is this ranking of Saudi pharmacies compiled?

    Each operator is ranked by the most recent store count it, its regulator or a covering broker has published — annual reports and Saudi Exchange announcements for Nahdi, Al-Dawaa, BinDawood and HMG, company websites for Innova, Adam and Boots, and broker or trade sources for United, Al Mujtama and Whites. Every row links to its source and states the disclosure date. The ranking is a footprint ranking, not a revenue or share ranking; category share, facings and pharmacist recommendation are measured through a commissioned BioNixus retail audit with an agreed sample frame and city coverage.

    How does BioNixus measure pharmacy market share in Saudi Arabia?

    Through a designed retail audit rather than an estimate. We define the store universe by format and city, draw a representative sample across chain, independent, hospital-affiliated, and in-store pharmacies, and measure availability, facings, pricing, and promotional execution in a repeatable way. Combined with pharmacist and shopper research, that produces category-level share and distribution metrics specific to the client product set.

    Which pharmacy chains in Saudi Arabia are publicly listed?

    Nahdi Medical Company and Al Dawaa Medical Services are both publicly listed on the Saudi Exchange (Tadawul). Listing matters commercially because listed operators disclose more about their strategy and operating model than private chains, and they typically run more structured category management, private label, and loyalty programmes. That raises the negotiation standard suppliers must meet when seeking listing and shelf space.

    How does Wasfaty affect retail pharmacy in Saudi Arabia?

    Wasfaty routes publicly funded prescriptions through a defined dispensing arrangement, which changes where patients collect medicines and therefore how footfall is distributed between retail chains, hospital pharmacies, and other channels. For suppliers, the practical implications concern prescription volume flow, product mix in retail baskets, and the relative commercial value of retail versus institutional channels, all of which BioNixus assesses within a channel study.

    Can BioNixus run mystery shopping across Saudi pharmacy chains?

    Yes. Mystery shopping is one of our core pharmacy channel services. We design standardised scenarios, brief and train shoppers, and field across chain, independent, and in-store formats in the cities relevant to the client. Outputs cover availability, pharmacist recommendation, competitor conquesting, and merchandising compliance, and repeat waves use consistent instruments so performance change can be tracked reliably over time.

    Get a scoped proposal in 48 hours

    Name the brand, the country, and the breakdown your syndicated feed cannot give you. We send a project- and country-priced proposal — typically within 48 hours.

    Request a proposalEmail us

    US No. +1 888 465 5557Europe No. +44 7727 666682Middle East, Africa and Asia No. +20 120 688 2323